HR-5775 : Still Just a Bill

Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018

This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).

The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs.

The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.

Action Timeline

Action DateTypeTextSource
2018-06-20IntroReferralReceived in the Senate and Read twice and referred to the Committee on Finance.Senate
2018-06-19FloorMotion to reconsider laid on the table Agreed to without objection.House floor actions
2018-06-19FloorOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5256-5257)House floor actions
2018-06-19FloorDEBATE - The House proceeded with forty minutes of debate on H.R. 5775.House floor actions
2018-06-19FloorConsidered under suspension of the rules. (consideration: CR H5256-5258)House floor actions
2018-06-19FloorMr. Curbelo (FL) moved to suspend the rules and pass the bill, as amended.House floor actions
2018-06-19CalendarsPlaced on the Union Calendar, Calendar No. 594.House floor actions
2018-06-19DischargeCommittee on Energy and Commerce discharged.House floor actions
2018-06-19CommitteeReported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.House floor actions
2018-06-04CommitteeReferred to the Subcommittee on Health.House committee actions
2018-05-16CommitteeOrdered to be Reported (Amended) by Voice Vote.House committee actions
2018-05-16CommitteeCommittee Consideration and Mark-up Session Held.House committee actions
2018-05-11IntroReferralReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2018-05-11IntroReferralReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2018-05-11IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

Health
See Subjects
  • Administrative law and regulatory procedures
  • Alternative treatments
  • Consumer affairs
  • Department of Health and Human Services
  • Drug therapy
  • Drug trafficking and controlled substances
  • Drug, alcohol, tobacco use
  • Government information and archives
  • Health care costs and insurance
  • Health care quality
  • Health information and medical records
  • Health personnel
  • Home and outpatient care
  • Hospital care
  • Medicare
  • Prescription drugs
  • Solid waste and recycling

Related Bills

See Related Bills